2 in 1 effects: injection to cure diabetes obesity reduction effects

According to information from the Ministry of health of America said, Liraglutide, a drug injected treatment of diabetes is the Government permission to use the 2014 also helps obese people lose weight effectively.

A study lasting for a year was announced on 1/7 on New England medicine Journal said thanks to the drugs on the market is Saxenda name of Novo Nordisk, most patients have reduced scale resulted during the 56-week study.

Testing at 191 locations on the 27 countries at ages over 18

The experiment was conducted randomly in 191 locations in 27 countries in Europe, North America, South America, Asia, Africa and Oceania.

The subjects involved in research are 18 years or older and have a body mass index (BMI) of 30 or higher. A person is said to have a healthy body weight if BMI in the 19-25. Among the study participants 3731, about 2/3 were taking the drug Saxenda combined exercise to improve your living habits.

The remaining group also involved in tuning the routine life but was no placebo healing effects. Those taking the drug prescribed high doses than prescribed for the treatment of diabetes (3 mg) and also be injected under the skin (1.8 mg).

Results after research showed the number of weight reduction on average 3 kg/person

Following results of experiments showed that those in the placebo group, reducing the average about 3 kg. Meanwhile, the average drug users reduced 3 times that figure.

In total, 63% of those in the group taking liraglutide reduced by at least 5% of the body weight, much higher than the rate of 27% in the placebo group. However, liraglutide also has side effects including stomach pain, gallstones and an increased risk of breast cancer.

Known to have about 35% of adult Americans (about 100 million), are having to live with obesity. America ever introduce two drugs against obesity in 2012 are not widely used due to carry more side effects.